Krishna Institute of Medical Sciences Limited (KIMS.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-251.3%

-₹1,103.02

vs ₹729.15 price

Levered DCF

-₹1,422.63

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

4.26

Safe zone

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	103.07×	64.33×	52.74×	33.33×	33.01×	37.13×	62.31×	-167.55×
P/B	11.07×	11.57×	8.94×	6.72×	7.92×	8.64×	12.42×	14.76×
P/S	6.37×	8.24×	6.61×	5.17×	6.66×	5.69×	6.61×	8.69×
EV / EBITDA	35.45×	33.02×	27.07×	18.39×	20.56×	20.45×	31.03×	96.84×
Gross margin	54.6%	62.5%	61.5%	61.8%	62.6%	62.4%	75.9%	72.7%
Operating margin	13.3%	20.5%	20.3%	22.6%	26.8%	23.5%	16.1%	13.3%
Net margin	6.2%	12.8%	12.5%	15.5%	20.2%	15.3%	10.6%	-5.2%
Current ratio	0.76×	0.83×	1.21×	1.61×	1.83×	1.62×	1×	0.87×
Debt / equity	1.89×	1.2×	0.74×	0.41×	0.18×	0.37×	0.62×	0.62×
Interest coverage	2.56×	6.14×	9.21×	13.13×	20.26×	8.28×	4.08×	2.48×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	10.7%	18.0%	17.0%	20.1%	24.0%	23.3%	19.9%	-8.8%
Return on invested capital	5.3%	8.9%	10.4%	13.7%	19.4%	18.2%	14.4%	12.7%
Return on assets	3.1%	6.7%	8.0%	11.4%	17.4%	14.0%	10.0%	-4.3%
Free cash flow yield	-4.5%	-1.7%	-0.8%	-1.3%	1.4%	3.5%	2.0%	0.7%
Earnings yield	1.0%	1.6%	1.9%	3.0%	3.0%	2.7%	1.6%	-0.6%
Enterprise value	₹290.6B	₹272.1B	₹176.6B	₹118.3B	₹112.2B	₹77.3B	₹77.5B	₹83.1B
Net debt / EBITDA	5.1×	3.01×	2.01×	0.96×	0.42×	0.7×	1.31×	3.83×
Cash conversion cycle (days)	12	-18	-9	-13	-23	-46	-81	-59